Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision is updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to the study details on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to study details or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.4.1 was added. The lapse in government funding notice and the prior Revision: v3.4.0 banner were removed.SummaryDifference0.1%

- Check62 days agoChange DetectedA notice banner about a lapse in government funding and potential website delays was added at the top of the page, directing users to cc.nih.gov and opm.gov for current status; the page also states that the NIH Clinical Center is open.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded a 'Show glossary' option and updated the page metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The prior version displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4', which are minor editorial changes that do not affect core study information.SummaryDifference0.1%

Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.